08Nov 2023
TAVR+LAAO Shows Promise for AF Patients with Severe Aortic Stenosis

TAVR+LAAO Shows Promise for AF Patients with Severe Aortic Stenosis

In a study, concomitant transcatheter aortic valve replacement (TAVR) and left atrial appendage occlusion (LAAO) have shown non-inferiority to TAVR with medical therapy in atrial fibrillation (AF) patients with severe aortic stenosis. The study involving 349 patients revealed that TAVR+LAAO had a lower risk of all-cause mortality, stroke, and significant bleeding at two years compared to TAVR+medical therapy. Although the combined procedure is a promising alternative to anticoagulants for stroke prevention in AF patients undergoing TAVR, its increased complexity and risks should be carefully weighed.

  • #cardiology

Like

Save

Share